Trial Profile
A Pilot Study of Neurocognitive Function in Patients Treated With Adjuvant Interferon Alpha-2b for High-Risk Melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 25 Mar 2014 New trial record